A Phenotypic High-Throughput Screen with RSV-Infected Primary Human Small Airway Epithelial Cells (SAECs).

about

A Phenotypic High-Throughput Screen with RSV-Infected Primary Human Small Airway Epithelial Cells (SAECs).

Item

http://www.wikidata.org/entity/Q35599468

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

A Phenotypic High-Throughput S ...... rway Epithelial Cells (SAECs).

@ast

A Phenotypic High-Throughput S ...... rway Epithelial Cells (SAECs).

@en

type

Item

label

A Phenotypic High-Throughput S ...... rway Epithelial Cells (SAECs).

@ast

A Phenotypic High-Throughput S ...... rway Epithelial Cells (SAECs).

@en

prefLabel

A Phenotypic High-Throughput S ...... rway Epithelial Cells (SAECs).

@ast

A Phenotypic High-Throughput S ...... rway Epithelial Cells (SAECs).

@en

P1476

A Phenotypic High-Throughput S ...... rway Epithelial Cells (SAECs).

@en

P2093

Aaron Goetz

http://www.w3.org/2001/XMLSchema#string

Chris Moore

http://www.w3.org/2001/XMLSchema#string

Dan Gillie

http://www.w3.org/2001/XMLSchema#string

Jeff Gobel

http://www.w3.org/2001/XMLSchema#string

Margaret Gartland

http://www.w3.org/2001/XMLSchema#string

Sarah Harris Gurley

http://www.w3.org/2001/XMLSchema#string

Sue Kadwell

http://www.w3.org/2001/XMLSchema#string

P2860

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

YM-53403, a unique anti-respiratory syncytial virus agent with a novel mechanism of action.

Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection.

Respiratory syncytial virus infection in elderly and high-risk adults.

Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV)

The burden of respiratory syncytial virus infection in young children

Oral efficacy of a respiratory syncytial virus inhibitor in rodent models of infection.

RSV604, a novel inhibitor of respiratory syncytial virus replication

Fatality rates in published reports of RSV hospitalizations among high-risk and otherwise healthy children.

Substituted benzimidazoles with nanomolar activity against respiratory syncytial virus.

P304

729-738

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1087057115580271

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25862685

http://www.w3.org/2001/XMLSchema#string